The oral and subcutaneous formulations are presently in phase 1 and 2 trials, where the oral molecule is given once daily and the efficacy and safety of the injection is being evaluated in patients when it is given every month as well as every three months
Because of increased androgen levels, the skin's sebaceous glands can generate more oil (sebum)
It will: Validate the efficacy signals at larger scale, and at higher resolution Identify predictive markers of safety and tolerability Assess drug-specific differences in different applications Evaluate discontinuation and rebound risk Enable head-to-head drug comparisons as data matures This moves the program from proof-of-concept to clinically actionable stratification
Healthcare professionals should evaluate each case individually, considering the temporal relationship between medication initiation and symptom onset, as well as alternative explanations for headache
At the research level, the molecule has also attracted attention for effects observed on hepatic fat content, cardiometabolic biomarkers, and glycemic control that go beyond simple body-composition changes
Although Wegovy and Semaglutide are closely related, they are distinct medications